NCT06095583 2024-06-21Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Shanghai Junshi Bioscience Co., Ltd.Phase 3 Recruiting756 enrolled